Edition:
United States

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

163.40SEK
21 Sep 2018
Change (% chg)

4.20kr (+2.64%)
Prev Close
159.20kr
Open
160.00kr
Day's High
167.40kr
Day's Low
160.00kr
Volume
136,255
Avg. Vol
156,175
52-wk High
209.00kr
52-wk Low
60.25kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 74.67 224.00 0.00 0.00
Earnings (per share)
Year Ending Dec-18 2 -9.50 -9.12 -9.88 -6.73
Year Ending Dec-19 3 -6.99 -4.77 -8.82 -4.80
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.45 32.71
P/E High - Last 5 Yrs. -- 279.26 47.27
P/E Low - Last 5 Yrs. -- 98.01 24.80
Beta -- 0.61 0.87
Price to Sales (TTM) -- 110.80 6.42
Price to Book (MRQ) 14.02 12.48 3.91
Price to Tangible Book (MRQ) 14.11 18.85 5.97
Price to Cash Flow (TTM) -- 62.31 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 179.03 8.45
Sales (TTM) vs TTM 1 Yr. Ago -- 93.99 6.71
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -93.53 283.55 25.51
EPS (TTM) vs TTM 1 Yr. Ago -23.48 -- --
EPS - 5 Yr. Growth Rate -- 23.64 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.63 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.20
Current Ratio (MRQ) 5.30 5.47 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.21
Total Debt to Equity (MRQ) 0.00 18.60 14.02
Interest Coverage (TTM) -- -198.17 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.73
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -176.77 15.89
Operating Margin (TTM) -- -608.74 3.72
Operating Margin - 5 Yr. Avg. -- -190.37 11.01
Pre-Tax Margin (TTM) -- -605.96 4.04
Pre-Tax Margin - 5 Yr. Avg. -- -192.95 11.19
Net Profit Margin (TTM) -- -600.63 0.77
Net Profit Margin - 5 Yr. Avg. -- -190.59 7.53
Effective Tax Rate (TTM) -- 11.58 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.15 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,333,198 715,149,750
Net Income/Employee (TTM) -11,977,190 -5,689,194 82,590,366
Receivable Turnover (TTM) -- 4.22 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.00 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.23 0.77 9.73
Return on Assets - 5 Yr. Avg. -- 2.50 10.90
Return on Investment (TTM) -61.27 1.54 12.72
Return on Investment - 5 Yr. Avg. -- 1.99 14.02
Return on Equity (TTM) -61.97 0.30 14.84
Return on Equity - 5 Yr. Avg. -- -2.37 15.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -38.98 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncopeptides AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.21 -- 99 76
13 Week 2.25 -- 99 58
26 Week 108.68 -- 99 46
52 Week 159.37 -- 99 88
YTD 104.25 -- 99 83
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.42%
# of Holders: 33
Total Shares Held: 35,422,895
3 Mo. Net Change: -335,393
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 9
# Reduced Positions: 9
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.